Study uncovers 23 new genetic markers linked to kidney health on the X-chromosome

A meta-analysis of 908,697 samples to investigate the genetic, sex-dependent basis of kidney traits.

Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors

This multicenter clinical trial compared AI-powered mobile phone diagnostic tools with human medical experts in diagnosing pigmented skin cancer. The study found that the AI

September 29, 2023

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy – Pharmaceutical Technology

Retinitis pigmentosa can eventually lead to complete blindness. Credit: GBJSTOCK via Shutterstock. Gene therapy company Skyline Therapeutics has secured an orphan drug designation from the

September 3, 2024

Sustained Viral Suppression in Multidrug-Resistant HIV With Lenacapavir at 3 Years

In 3-year data from the CAPELLA study, the subcutaneous, long-acting capsid inhibitor lenacapavir (Sunlenca) demonstrated sustained suppression with no emergence of resistance in highly treatment-experienced

November 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.